Dr Shannon Scharder and Nelson Vergel talk about multidrug resistance, Prezista, Fuzeon, Integrase
June 28, 2006
Transcript of The Body’s Live Chat on Multidrug Resistance
July 20, 2006

HIV Lecture in Houston – July 12

Open to patients and clinicians

Date: Wednesday, July 12

Time : 6:30 pm – 8:30 pm

Place: Lovett Inn ( http://www.lovettinn.com/main.php )

Speakers: Dr Shannon Schrader and Nelson Vergel

TOPICS:

1- Updated review of HIV pipeline products

2- How to best maximize the effects of Prezista, the newly approved protease inhibitor for multi-protease resistant virus

3- What is virtual monotherapy and what are its risks?

4- What are the best predictors of treatment response in patients with multidrug resistant virus?

5- Information on Fuzeon’s needle free injection device (BOSS Study)

6- Integrase Inhibitors- Why the hype?

7- Are oral entry inhibitors safe and effective? What do the studies so far show?

8- Gene therapy in HIV- An update

9- Questions and Answers

Reply to this email or nelsonvergel@yahoo.com to reserve a seat since space is very limited.

For those who cannot attend, there will be a live chat at thebody.com on July 10th at 2:30 pm Central. Questions can be sent in now. A full transcript will be available after the chat. For more information:
http://www.thebody.com/submit/?/chat/main_071006.html

Nelson Vergel
Nelson Vergel
Chemical engineer, 34+ year HIV and cancer survivor, health author and educator . Founder of DiscountedLabs.com , ExcelMale.com , and PowerUSA.org

Comments are closed.